The Beatles, Steve Jobs, and Bob Dylan are just a few innovators who credited the hallucinogenic LSD (aka Lysergic acid diethylamide) for their creative breakthroughs. The lab results are catching up. Dr. Isabel Wießner led Brazil’s first double-blind, placebo-controlled study to test the effects of LSD on humans. In this episode, she reveals the effects of LSD on consciousness, thinking, creativity, and cognition.

We discuss what differentiates an LSD session from being a blip of psychosis to a healing therapeutic experience, and she shares why LSD shows promise in treating conditions involving memory and language decline such as brain injury, stroke, or dementia.